Literature DB >> 30268554

Intracranial Dural Arteriovenous Fistula as a Reversible Cause of Dementia: Case Series and Literature Review.

Arnaldo Brito1, Anderson Chun On Tsang2, Christopher Hilditch3, Patrick Nicholson3, Timo Krings3, Waleed Brinjikji3.   

Abstract

OBJECTIVE: Intracranial dural arteriovenous fistulas (DAVFs) can manifest with a reversible form of dementia and parkinsonism that may be related to medullary venous hypertension and impaired cortical venous drainage. We report a consecutive case series of patients with DAVFs who presented with cognitive decline and report angioarchitecture and outcomes of treatment.
METHODS: From a prospectively collected database of 389 cranial DAVFs, we identified patients who presented with progressive dementia. Data collected included demographic characteristics, other presenting symptoms, fistula location and type, preoperative and postoperative imaging findings, and treatment outcomes. Descriptive statistics were reported.
RESULTS: Of 389 patients with DAVF, 6 patients with progressive dementia (1.4%) were identified. All patients were male. Mean patient age was 68.6 years. Four patients had superior sagittal sinus DAVFs, 1 patient had a tentorial DAVF, and 1 patient had a transverse sinus DAVF. All patients had evidence of medullary venous hypertension on imaging with either reflux and arterialization of the transmedullary veins or venous congestion of the transmedullary veins. All patients underwent endovascular treatment and had reversal of dementia-related symptoms after a mean follow-up of 6.2 months.
CONCLUSIONS: Cognitive decline is a rare but reversible manifestation of DAVFs that have impaired venous drainage of the transmedullary veins and associated medullary venous hypertension.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cortical venous reflux; Dementia; Dural arteriovenous fistula; Venous hypertension

Mesh:

Year:  2018        PMID: 30268554     DOI: 10.1016/j.wneu.2018.09.161

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  6 in total

1.  Evaluation of cerebral arteriovenous shunts: a comparison of parallel imaging time-of-flight magnetic resonance angiography (TOF-MRA) and compressed sensing TOF-MRA to digital subtraction angiography.

Authors:  Akihiko Sakata; Yasutaka Fushimi; Tomohisa Okada; Satoshi Nakajima; Takuya Hinoda; Peter Speier; Michaela Schmidt; Christoph Forman; Kazumichi Yoshida; Hiroharu Kataoka; Susumu Miyamoto; Yuji Nakamoto
Journal:  Neuroradiology       Date:  2020-10-15       Impact factor: 2.804

2.  Impaired intrinsic functional connectivity among medial temporal lobe and sub-regions related to memory deficits in intracranial dural arteriovenous fistula.

Authors:  Josline Elsa Joseph; Sabarish Sekar; Santhosh Kumar Kannath; Ramshekhar N Menon; Bejoy Thomas
Journal:  Neuroradiology       Date:  2021-04-10       Impact factor: 2.804

Review 3.  Endovascular Management of Intracranial Dural AVFs: Principles.

Authors:  K D Bhatia; H Lee; H Kortman; J Klostranec; W Guest; T Wälchli; I Radovanovic; T Krings; V M Pereira
Journal:  AJNR Am J Neuroradiol       Date:  2021-10-21       Impact factor: 3.825

4.  Dural arteriovenous fistula presenting as thalamic dementia: a case description with rare imaging findings.

Authors:  Renjie Liu; Yuhao Zhao; Haoyuan Yin; Zhongqiang Shi; Xuan Chen
Journal:  Quant Imaging Med Surg       Date:  2022-05

5.  A proposed framework for cerebral venous congestion.

Authors:  Anirudh Arun; Matthew R Amans; Nicholas Higgins; Waleed Brinjikji; Mithun Sattur; Sudhakar R Satti; Peter Nakaji; Mark Luciano; Thierry Agm Huisman; Abhay Moghekar; Vitor M Pereira; Ran Meng; Kyle Fargen; Ferdinand K Hui
Journal:  Neuroradiol J       Date:  2021-07-05

Review 6.  The Challenging Clinical Management of Patients with Cranial Dural Arteriovenous Fistula and Secondary Parkinson's Syndrome: Pathophysiology and Treatment Options.

Authors:  Julia Velz; Zsolt Kulcsar; Fabian Büchele; Heiko Richter; Luca Regli
Journal:  Cerebrovasc Dis Extra       Date:  2020-10-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.